HLS ASX · Health Care

Healius Ltd

Announcements, last 12 months: 115
Price sensitive, last 12 months: 12
Followed on InvestorPA: Moderate (Among the 13% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
23 Oct 2026, 3:06 PM	Change of Director's Interest Notice - Paul Anderson
23 Oct 2026, 3:01 PM	Notification regarding unquoted securities - HLS
23 Oct 2026, 2:57 PM	Notification regarding unquoted securities - HLS
22 Oct 2026, 2:42 PM	2026 AGM - Voting Results
22 Oct 2026, 9:48 AM	2026 AGM - CEO Presentation
22 Oct 2026, 9:47 AM	2026 AGM - Chair & CEO Addresses
6 Oct 2026, 6:57 PM	Becoming a substantial holder from MUFG
5 Oct 2026, 5:48 PM	Becoming a substantial holder
1 Oct 2026, 5:47 PM	Ceasing to be a substantial holder from MUFG
1 Oct 2026, 3:51 PM	Ceasing to be a substantial holder

Sign in to see all HLS announcements.

Guidance history

19 Aug 2026	FY27 EBIT expected to be in line with consensus of $39.7m
19 Aug 2026	Healius expects FY 2027 EBIT to be in line with consensus at $39.7 million.
26 Jun 2026	Total annual revenue under the initial terms of the new agreements is expected to be approximately $45m.

Sign in to see the full guidance history.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow HLS to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.